Membrane-Targeting Triphenylphosphonium Functionalized Ciprofloxacin for Methicillin-Resistant Staphylococcus aureus (MRSA)
Open Access
- 30 October 2020
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 9 (11) , 758
Abstract
Multidrug-resistant (MDR) bacteria have become a severe problem for public health. Developing new antibiotics for MDR bacteria is difficult, from inception to the clinically approved stage. Here, we have used a new approach, modification of an antibiotic, ciprofloxacin (CFX), with triphenylphosphonium (TPP, PPh3) moiety via ester- (CFX-ester-PPh3) and amide-coupling (CFX-amide-PPh3) to target bacterial membranes. In this study, we have evaluated the antibacterial activities of CFX and its derivatives against 16 species of bacteria, including MDR bacteria, using minimum inhibitory concentration (MIC) assay, morphological monitoring, and expression of resistance-related genes. TPP-conjugated CFX, CFX-ester-PPh3, and CFX-amide-PPh3 showed significantly improved antibacterial activity against Gram-positive bacteria, Staphylococcus aureus, including MDR S. aureus (methicillin-resistant S. aureus (MRSA)) strains. The MRSA ST5 5016 strain showed high antibacterial activity, with MIC values of 11.12 µg/mL for CFX-ester-PPh3 and 2.78 µg/mL for CFX-amide-PPh3. The CFX derivatives inhibited biofilm formation in MRSA by more than 74.9% of CFX-amide-PPh3. In the sub-MIC, CFX derivatives induced significant morphological changes in MRSA, including irregular deformation and membrane disruption, accompanied by a decrease in the level of resistance-related gene expression. With these promising results, this method is very likely to combat MDR bacteria through a simple TPP moiety modification of known antibiotics, which can be readily prepared at clinical sites.Keywords
All Related Versions
Funding Information
- National Research Foundation of Korea (NRF-2019-M3A9H1103783, NRF-2018-M3A9H3021707, NRF-2018-R1A6A1A03025124, NRF-2018-R1D1A1B07043383, NRF-2018-R1C1B5043292, NRF-2018-R1A3B1052702, NRF-2014-H1A2A1020978, NRF-2019-R1A6A3A01096972)
This publication has 39 references indexed in Scilit:
- Development of Quorum-Based Anti-Virulence Therapeutics Targeting Gram-Negative Bacterial PathogensInternational Journal of Molecular Sciences, 2013
- Investigation of mutation distribution in DNA gyrase and topoisomerase IV genes in ciprofloxacin-non-susceptible Enterobacteriaceae isolated from blood cultures in a tertiary care university hospital in South Korea, 2005–2010International Journal of Antimicrobial Agents, 2013
- Quinolone Resistance: Much More than PredictedFrontiers in Microbiology, 2011
- Damage of the Bacterial Cell Envelope by Antimicrobial Peptides Gramicidin S and PGLa as Revealed by Transmission and Scanning Electron MicroscopyAntimicrobial Agents and Chemotherapy, 2010
- Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPEThe Journal of Infectious Diseases, 2008
- Physicochemical Properties of Antibacterial Compounds: Implications for Drug DiscoveryJournal of Medicinal Chemistry, 2008
- Comparison of multiple methods for quantification of microbial biofilms grown in microtiter platesJournal of Microbiological Methods, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Rapid Development of Ciprofloxacin Resistance in Methicillin-Susceptible and -Resistant Staphylococcus aureusThe Journal of Infectious Diseases, 1991
- Dissolution of Natural Mineral and Man-Made Vitreous Fibers in Karnovsky's and Formalin FixativesInhalation Toxicology, 1991